Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Heather Preston


  • Director at Akouos Inc. (AKUS), 2020-07-02
  • Director at Fusion Pharmaceuticals Inc. (FUSN), 2020-07-02
  • at Karuna Therapeutics Inc. (KRTX), 2020-06-08
  • Director at Alder Biopharmaceuticals Inc (ALDR), 2019-10-24
  • Director at Entasis Therapeutics Holdings Inc. (ETTX), 2019-06-21
  • Director at Otonomy Inc. (OTIC), 2019-06-13
  • Director at Albireo Pharma Inc. (ALBO), 2017-01-25
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AKUS $17.00 5,882 Director 5,882 2020-06-30 Filing
AKUS $17.00 294,117 Director 1,794,088 2020-06-30 Filing
FUSN $17.00 8,823 Director 8,823 2020-06-30 Filing
KRTX $74.91 500 Director 5,450 2020-03-12 Filing
KRTX $73.00 500 Director 4,950 2020-03-12 Filing